Atlas Trials

Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients

Clinical trial NCT02500849 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02500849
Sponsor
City of Hope Medical Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
HIV
Start date
2016-03-10
Primary completion
2026-08-24
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.